M. gallisepticum strain S6 was inoculated into the IC and exposed for five consecutive days to once-daily danofloxacin replenishments in the in vitro dynamic model. Panels A1 to A7: Danofloxacin concentrations at the indicated times after the administration of each dose. Panels B1 to B7: Loss of susceptibility shown as an increase in average MIC for each group. Panels C1 to C7: The fraction of resistant mutants in each group was determined daily as the number of colonies grown on danofloxacin-containing agar (1 × MIC) relative to the number that grew on drug-free agar.</p
We demonstrate using an in vitro pharmacodynamic model that the likelihood of selection of Escherich...
The study was to explore the rational use of danofloxacin against Mycoplasma gallisepticum (MG) base...
Fluoroquinolones therapeutic efficacy is closely related to the achievement of the highest concentra...
The simulated C0 concentrations (where C0 is the initial danofloxacin concentration) were administra...
Mycoplasma gallisepticum is a serious pathogen for poultry that causes chronic respiratory disease i...
Mycoplasma gallisepticum is a serious pathogen for poultry that causes chronic respiratory disease i...
The in vitro model that simulates the pharmacokinetics of danofloxacin in lung tissues of the M. gal...
<div><p><i>Mycoplasma gallisepticum</i> is a common etiological cause of a chronic respiratory disea...
Mycoplasma gallisepticum is a common etiological cause of a chronic respiratory disease in chickens;...
<p>Minimum inhibitory concentrations for danofloxacin, doxycycline, tilmicosin, tylvalosin and valne...
To evaluate the relationship between pharmacokinetic/pharmacodynamic (PK/PD) parameters and changes ...
An agar plate assay was developed for detecting the induction of drug-resistant mycobacterial mutant...
Danofloxacin (CP-76,136) is in a class of agents that inhibit DNA gyrase and trigger induction of th...
Studies with fluoroquinolones have led to a general method for restricting the selection of antibiot...
The effect of antimicrobial concentration on colony-forming ability of resistant mutant subpopulatio...
We demonstrate using an in vitro pharmacodynamic model that the likelihood of selection of Escherich...
The study was to explore the rational use of danofloxacin against Mycoplasma gallisepticum (MG) base...
Fluoroquinolones therapeutic efficacy is closely related to the achievement of the highest concentra...
The simulated C0 concentrations (where C0 is the initial danofloxacin concentration) were administra...
Mycoplasma gallisepticum is a serious pathogen for poultry that causes chronic respiratory disease i...
Mycoplasma gallisepticum is a serious pathogen for poultry that causes chronic respiratory disease i...
The in vitro model that simulates the pharmacokinetics of danofloxacin in lung tissues of the M. gal...
<div><p><i>Mycoplasma gallisepticum</i> is a common etiological cause of a chronic respiratory disea...
Mycoplasma gallisepticum is a common etiological cause of a chronic respiratory disease in chickens;...
<p>Minimum inhibitory concentrations for danofloxacin, doxycycline, tilmicosin, tylvalosin and valne...
To evaluate the relationship between pharmacokinetic/pharmacodynamic (PK/PD) parameters and changes ...
An agar plate assay was developed for detecting the induction of drug-resistant mycobacterial mutant...
Danofloxacin (CP-76,136) is in a class of agents that inhibit DNA gyrase and trigger induction of th...
Studies with fluoroquinolones have led to a general method for restricting the selection of antibiot...
The effect of antimicrobial concentration on colony-forming ability of resistant mutant subpopulatio...
We demonstrate using an in vitro pharmacodynamic model that the likelihood of selection of Escherich...
The study was to explore the rational use of danofloxacin against Mycoplasma gallisepticum (MG) base...
Fluoroquinolones therapeutic efficacy is closely related to the achievement of the highest concentra...